Manulife (Manufacturers Life Insurance)
CRMD icon

Manulife (Manufacturers Life Insurance)’s CorMedix CRMD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135K Sell
19,901
-2,298
-10% -$17K ﹤0.01% 2559
2025
Q4 		$258K Sell
22,199
-1,649
-7% -$18.2K ﹤0.01% 2413
2025
Q3 		$277K Buy
23,848
+755
+3% +$9.13K ﹤0.01% 2424
2025
Q2 		$285K Buy
23,093
+2,259
+11% +$24.9K ﹤0.01% 2406
2025
Q1 		$128K Sell
20,834
-463
-2% -$4.79K ﹤0.01% 2633
2024
Q4 		$173K Sell
21,297
-1,049
-5% -$10.5K ﹤0.01% 2676
2024
Q3 		$181K Sell
22,346
-844
-4% -$4.57K ﹤0.01% 2706
2024
Q2 		$100K Buy
23,190
+2,700
+13% +$13.7K ﹤0.01% 2822
2024
Q1 		$86.9K Buy
20,490
+358
+2% +$1.24K ﹤0.01% 2810
2023
Q4 		$75.7K Hold
20,132
– – ﹤0.01% 2877
2023
Q3 		$74.5K Buy
20,132
+1,004
+5% +$3.99K ﹤0.01% 2885
2023
Q2 		$75.8K Buy
+19,128
New +$94.6K ﹤0.01% 2927
2022
Q2 		– Sell
-15,523
Closed -$85.1K – 3037
2022
Q1 		$85.1K Sell
15,523
-3,695
-19% -$16.9K ﹤0.01% 2982
2021
Q4 		$87 Buy
+19,218
New +$95.4K ﹤0.01% 3067
2021
Q3 		– Sell
-22,638
Closed -$155K – 3161
2021
Q2 		$155K Buy
22,638
+3,397
+18% +$27K ﹤0.01% 3186
2021
Q1 		$192K Sell
19,241
-193
-1% -$2.03K ﹤0.01% 2906
2020
Q4 		$144K Buy
19,434
+2,022
+12% +$13.7K ﹤0.01% 2879
2020
Q3 		$105K Buy
17,412
+1,075
+7% +$5.4K ﹤0.01% 2784
2020
Q2 		$101K Sell
16,337
-530
-3% -$2.45K ﹤0.01% 2751
2020
Q1 		$61K Buy
16,867
+2,454
+17% +$13.9K ﹤0.01% 2695
2019
Q4 		$105K Sell
14,413
-589
-4% -$3.6K ﹤0.01% 2790
2019
Q3 		$100K Sell
15,002
-17
-0.1% -$143 ﹤0.01% 2818
2019
Q2 		$135K Buy
+15,019
New +$118K ﹤0.01% 2809
2016
Q2 		– Sell
-1,211
Closed -$15K – 4259
2016
Q1 		$15K Buy
+1,211
New +$11.8K ﹤0.01% 3550

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Manulife (Manufacturers Life Insurance)'s CRMD Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its CorMedix (CRMD) stake by 10% in Q1 2026, selling an estimated $17K and leaving 19,901 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Manulife (Manufacturers Life Insurance) first reported a position in CRMD in Q1 2016 and has held it in 24 quarters since. The position peaked at $285K in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 19,901 shares of CorMedix worth $135K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,298 CorMedix shares in Q1 2026, an estimated $17K.
  • CorMedix made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2559 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in CorMedix in Q1 2016 and has held it in 24 quarters since.
  • Manulife (Manufacturers Life Insurance)'s CorMedix position peaked at $285K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.